ERBB2 and androgen insensitivity syndrome: Among ERBB2-mutant tumors, 20ins were most frequently identified and showed a reverse pattern by invasion levels with the highest mutation rate in AIS and lowest in IAC (20.3% vs. 14.0 % vs. 3.0%; Fig. 4B).